The Act that addresses the problem that patients were not allowed to return drugs to a DEA registrant is:

• A. The Harrison Act
• B. The Secure and Responsible Drug Disposal Act
• C. The Affordable Drug Prescription Drug Disposal Act
• D. The Shirley Amendment

Answer: (B)

The issue being tested is how policy changes enable lawful return and disposal of unused medications to reduce misuse and improper disposal. The Secure and Responsible Drug Disposal Act of 2010 created a framework for take-back programs and allowed DEA-registered entities to collect unwanted medications, including controlled substances, from patients. This directly addresses the previous gap where patients often had no legal way to return drugs to a pharmacy or other registered site, leading to unsafe disposal or keeping leftovers that could be diverted or misused.

Under this act, authorized collectors such as pharmacies, hospitals, long-term care facilities, and certain law enforcement or community sites can operate take-back programs, including mail-back and community drop-off events. Collected medicines are then disposed of through approved channels, like transfer to a reverse distributor or destruction by incineration, with safeguards to maintain chain of custody and proper recordkeeping. The overall goal is to provide a safe, legal path for disposal, especially of opioids, to minimize harm from unused medications and reduce opportunities for diversion.

Older laws mentioned here address different aspects of drug control and enforcement (for example, regulating manufacture, distribution, or misbranding of drugs) and do not establish take-back mechanisms. The other options listed are not the law that created patient take-back programs.